A novel case of prolonged Ifosfamide encephalopathy and long-term treatment with methylene blue: a case report and review of literature

BACKGROUND: Encephalopathy following Ifosfamide treatment is a well-described phenomenon that is typically treated with Methylene Blue (MB). Chloroacetaldehyde, a potentially neurotoxic metabolite of Ifosfamide is hypothesized to cause this encephalopathy. Current guidelines for treatment is to stop...

Descripción completa

Detalles Bibliográficos
Autores principales: Chain, Gabriel, Kalia, Mudit, Kestenbaum, Karen, Pappas, Lara, Sechser-Perl, Anna, Campino, Gadi Abebe, Zaghloul, Nibal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807677/
https://www.ncbi.nlm.nih.gov/pubmed/35109795
http://dx.doi.org/10.1186/s12887-022-03144-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807677/
https://www.ncbi.nlm.nih.gov/pubmed/35109795
http://dx.doi.org/10.1186/s12887-022-03144-1

Ejemplares similares